NFT
IMNM icon

Nan Fung Trinity’s Immunome IMNM Stock Holding History

Nan Fung Trinity’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.6M Hold
714,553
– – 1.72% 21
2025
Q4 		$15.3M Buy
714,553
+122,450
+21% +$2.15M 1.22% 36
2025
Q3 		$6.93M Buy
592,103
+43,253
+8% +$430K 0.69% 45
2025
Q2 		$5.1M Buy
+548,850
New +$4.5M 0.61% 46

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Nan Fung Trinity's IMNM Position: Q1 2026 in Review

Nan Fung Trinity held its Immunome (IMNM) position steady in Q1 2026 at 714,553 shares worth $15.6M. The position accounts for 1.72% of the portfolio, ranked #21.

Nan Fung Trinity first reported a position in IMNM in Q2 2025 and has held it in 4 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Nan Fung Trinity held 714,553 shares of Immunome worth $15.6M as of Q1 2026.
  • Nan Fung Trinity left its Immunome share count unchanged in Q1 2026.
  • Immunome made up 1.72% of Nan Fung Trinity's portfolio in Q1 2026, its #21 holding.
  • Nan Fung Trinity first reported a position in Immunome in Q2 2025 and has held it in 4 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Nan Fung Trinity's 13F filing for Q1 2026, filed 5 May 2026.